Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 26351-26400 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06219525
Higher and Standard Doses of Enteral Zinc Supplementation in Very Preterm Infants
NARecruiting
120 participants
Started: Apr 2, 2024 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT06592716
Can Recurrence of Cancer in the Oropharynx Be Detected by Blood Samples?
NARecruiting
200 participants
Started: Apr 2, 2024 · Completed: Dec 31, 2028
5 conditions3 sponsors1 location
NCT05966194
RRx-001 for Reducing Oral Mucositis in Patients Receiving Chemotherapy and Radiation for Head and Neck Cancer
PHASE2Recruiting
216 participants
Started: Apr 2, 2024 · Completed: Oct 1, 2025
1 condition1 sponsor14 locations
NCT06387121
Efficacy and Safety of Low-dose Chemotherapy Plus Immuno-targeted Drugs in Newly Diagnosed Elderly/Unfit Ph- B-ALL
PHASE2Recruiting
53 participants
Started: Apr 2, 2024 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT05949567
Does Position Influence the Diagnosis of Detrusor Overactivity in a Neurological Population
NARecruiting
160 participants
Started: Apr 2, 2024 · Completed: Apr 2, 2026
2 conditions1 sponsor1 location
NCT06127303
Toripalimab Combined With Cryoablation for First-line Oligo-progression in Driver-negative Advanced NSCLC
PHASE2Recruiting
54 participants
Started: Apr 2, 2024 · Completed: Apr 2, 2028
1 condition1 sponsor3 locations
NCT06491966
Clinical Outcomes and Inflammatory Responses in Viral vs. Bacterial Sepsis
N/ARecruiting
300 participants
Started: Apr 2, 2024 · Completed: Jul 10, 2024
7 conditions1 sponsor1 location
NCT06253078
Ciprofol EC50 for Inducing Loss of Consciousness in Elderly Patients
PHASE4Recruiting
150 participants
Started: Apr 2, 2024 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT06609824
Learn to Dare! Leiden
NARecruiting
48 participants
Started: Apr 2, 2024 · Completed: Dec 31, 2028
2 conditions2 sponsors1 location
NCT06003556
PSMA-Guided Ablation of the Prostate
PHASE2Recruiting
138 participants
Started: Apr 2, 2024 · Completed: Feb 26, 2029
2 conditions1 sponsor3 locations
NCT06274697
Validation of a Magnetic Sensor in Arterial Flow Recording, Compared With the Reference Method, at Various Peripheral Arterial Sites
NARecruiting
70 participants
Started: Apr 2, 2024 · Completed: Oct 31, 2025
1 condition2 sponsors1 location
NCT06346600
A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD
N/ARecruiting
83 participants
Started: Apr 2, 2024 · Completed: Mar 31, 2031
1 condition1 sponsor10 locations
NCT06341621
Chemotherapy Omission in ER+/HER2- Breast Cancer With 1-3 Positive Lymph Nodes Receiving Extended Adjuvant Abemaciclib
PHASE3Recruiting
1,900 participants
Started: Apr 2, 2024 · Completed: Jan 1, 2029
1 condition1 sponsor1 location
NCT06243978
Effectiveness of a Digital Health Application for Primary Hypertension (Liebria)
NARecruiting
328 participants
Started: Apr 2, 2024 · Completed: Apr 15, 2025
1 condition3 sponsors1 location
NCT05759065
A Hybrid Effectiveness Implementation Trial Evaluating Behavioral Treatments for Insomnia for Socioeconomically Disadvantaged Adults in Primary Care
NARecruiting
350 participants
Started: Apr 2, 2024 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT06373471
Improving Quality of Life in Older Patients With Frailty and Hematological Cancer Through Geriatric Assessment
NARecruiting
152 participants
Started: Apr 2, 2024 · Completed: Sep 30, 2026
5 conditions4 sponsors1 location
NCT04629352
Effect of Neuroplasticity Modulation in tDCS Treatment Response Among Schizophrenia Patients With Auditory Hallucination
NARecruiting
72 participants
Started: Apr 2, 2024 · Completed: Aug 31, 2026
2 conditions1 sponsor1 location
NCT06396312
Deep Phenotyping for Clinical Inferring Response in Treatment Resistant Depression
N/ARecruiting
130 participants
Started: Apr 2, 2024 · Completed: Apr 1, 2029
7 conditions1 sponsor1 location
NCT06223828
Azithromycin for Critical Asthma - Pediatrics
PHASE2/PHASE3Recruiting
100 participants
Started: Apr 2, 2024 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT06311812
Retrospective Review on Uterovaginal Anomalies
N/ARecruiting
400 participants
Started: Apr 1, 2024 · Completed: Feb 14, 2025
2 conditions1 sponsor1 location
NCT06356597
Tislelizumab With Fruquintinib, Metronidazole, in Mismatch Repair-proficient or Microsatellite Stability, Advanced Colorectal Cancer: a Multicenter, Single Arm, Clinical Trial
PHASE2Recruiting
25 participants
Started: Apr 1, 2024 · Completed: Dec 12, 2027
1 condition1 sponsor2 locations
NCT06357312
Influence of Static Distal Locking of a Short Proximal Femoral Nail
NARecruiting
200 participants
Started: Apr 1, 2024 · Completed: Apr 1, 2024
1 condition1 sponsor1 location
NCT06855251
SENSing Inner BodiLy State: Understanding the Role of Interoception in obEsity
N/ARecruiting
32 participants
Started: Apr 1, 2024 · Completed: Mar 30, 2026
2 conditions1 sponsor1 location
NCT06494514
NALIRIFOX Combined With PD-1 Sequential Radiotherapy Versus AG Combined With PD-1 Sequential Radiotherapy as First-line Treatment of Locally Advanced Pancreatic Cancer
NARecruiting
40 participants
Started: Apr 1, 2024 · Completed: Apr 1, 2027
1 condition1 sponsor2 locations
NCT06421558
Impact of Direct Current Electrical Stimulation on Treatment of Lumbosacral Radiculopathy
NARecruiting
150 participants
Started: Apr 1, 2024 · Completed: Aug 1, 2025
3 conditions1 sponsor16 locations
NCT06799858
Localization of Breast Cancer with the Sirius Pintuition Magnetic Seed
N/ARecruiting
40 participants
Started: Apr 1, 2024 · Completed: Jun 1, 2025
1 condition1 sponsor1 location
NCT06348381
Prediction of Anastomotic Complications and Recurrent Laryngeal Nerve Injury Based on Postoperative Early Endoscopic Evaluation
N/ARecruiting
250 participants
Started: Apr 1, 2024 · Completed: Dec 31, 2025
5 conditions1 sponsor1 location
NCT06312891
Value of Heart Rate Lowering Therapy in Acute Myocarditis
N/ARecruiting
150 participants
Started: Apr 1, 2024 · Completed: Jun 1, 2025
1 condition1 sponsor1 location
NCT06346535
PrimeCog: Primary Care Cognitive Testing
N/ARecruiting
300 participants
Started: Apr 1, 2024 · Completed: Apr 1, 2029
3 conditions1 sponsor1 location
NCT06420310
Pesticides and Parkinson´s Disease
N/ARecruiting
260 participants
Started: Apr 1, 2024 · Completed: Dec 30, 2028
1 condition1 sponsor1 location
NCT06311929
Precision Adjuvant Therapy After Surgery for Hepatocellular Carcinoma
PHASE4Recruiting
300 participants
Started: Apr 1, 2024 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT06087757
Clemastine Treatment in Individuals With Williams Syndrome
PHASE3Recruiting
30 participants
Started: Apr 1, 2024 · Completed: Dec 31, 2025
1 condition2 sponsors2 locations
NCT06300515
Exercise and Health Counseling in Pediatric Hematopoietic Stem Cell Transplantation
NARecruiting
48 participants
Started: Apr 1, 2024 · Completed: Dec 31, 2026
1 condition5 sponsors1 location
NCT06322251
Identification of Interpesonal Violence
NARecruiting
200 participants
Started: Apr 1, 2024 · Completed: Jun 30, 2028
4 conditions4 sponsors1 location
NCT06283888
CYP2C19 Genotype-Guided P2Y12 Receptor Inhibitor Selection After Complex Percutaneous Coronary Intervention
PHASE4Recruiting
1,200 participants
Started: Apr 1, 2024 · Completed: Dec 1, 2028
2 conditions1 sponsor1 location
NCT06106984
Home-based Rehabilitation Intervention for Phantom Limb Pain in Veterans With Lower Limb Amputations
NARecruiting
36 participants
Started: Apr 1, 2024 · Completed: Mar 31, 2029
1 condition1 sponsor1 location
NCT06481072
Digital Psychological Intervention for Pediatric Functional Abdominal Pain Disorders in Primary Care
NARecruiting
300 participants
Started: Apr 1, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06449391
The Application of Root Analogy Implant in Immediate Implantation
NARecruiting
10 participants
Started: Apr 1, 2024 · Completed: Jun 30, 2026
3 conditions1 sponsor1 location
NCT06386796
Renal Resistive Index as a Predictor of Acute Renal Impairment in High-risk Patients
N/ARecruiting
100 participants
Started: Apr 1, 2024 · Completed: Jun 6, 2025
2 conditions1 sponsor1 location
NCT06347939
Mediastinal EBUS Cryobiopsy Study In Sweden
N/ARecruiting
200 participants
Started: Apr 1, 2024 · Completed: Dec 31, 2028
5 conditions1 sponsor2 locations
NCT06437496
68Ga-AAZTA-093 PET/CT: First-in-human Study
EARLY_PHASE1Recruiting
30 participants
Started: Apr 1, 2024 · Completed: Oct 1, 2024
1 condition1 sponsor1 location
NCT06675877
Impact of Virtual Reality on Pediatric Patients with ESRD on Regular Hemodialysis Through Arteriovenous Fistula.
NARecruiting
60 participants
Started: Apr 1, 2024 · Completed: Nov 30, 2024
2 conditions1 sponsor1 location
NCT06044623
Implementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients
PHASE3Recruiting
495 participants
Started: Apr 1, 2024 · Completed: May 31, 2029
5 conditions19 sponsors12 locations
NCT06402409
Exploring Multimorbidity in Patients With Spinal Pain
N/ARecruiting
2,000 participants
Started: Apr 1, 2024 · Completed: Sep 1, 2026
3 conditions1 sponsor1 location
NCT06766006
ECMO LEft Ventricle UNloading Strategy
N/ARecruiting
500 participants
Started: Apr 1, 2024 · Completed: Apr 1, 2026
3 conditions2 sponsors1 location
NCT06548516
Maxillary Labial Frenectomy: Diode Lasers Versus Surgical Scalpel
NARecruiting
43 participants
Started: Apr 1, 2024 · Completed: Sep 30, 2024
1 condition1 sponsor1 location
NCT06387056
Genomic Biomarker-guided Neoadjuvant Therapy for Prostate Cancer (SEGNO)
PHASE2Recruiting
40 participants
Started: Apr 1, 2024 · Completed: Apr 1, 2029
2 conditions1 sponsor1 location
NCT05668026
Administration of Venetoclax to Promote Apoptosis of HIV-infected Cells and Reduce the Size of the HIV Reservoir Among People Living With HIV on ART
PHASE1/PHASE2Recruiting
18 participants
Started: Apr 1, 2024 · Completed: Dec 1, 2026
1 condition5 sponsors1 location
NCT05110066
BPA vs. PEA in CTEPH
NARecruiting
139 participants
Started: Apr 1, 2024 · Completed: Apr 1, 2028
1 condition8 sponsors2 locations
NCT06389123
Molecularly Targeted Theranostic Approach for the Detection and Treatment of Metastatic Carcinomas
PHASE1Recruiting
40 participants
Started: Apr 1, 2024 · Completed: Mar 31, 2028
1 condition2 sponsors1 location